Printer Friendly

Ontario government to invest USD25m in chronic disease study over five years.

M2 PHARMA-June 23, 2015-Ontario government to invest USD25m in chronic disease study over five years


The Ontario government is investing USD25m in chronic disease study over five years, it was reported on Monday.

The government is investing to study new treatments and therapies for people living with chronic diseases including cancer, multiple sclerosis and diabetes.

The funds will be offered to the Ontario Institute for Regenerative Medicine's 150 stem cell and regenerative medicine scientists, clinicians and engineers. It will be utilised to examine new chronic disease treatments. Regenerative medicine studies indicate how to replace or regenerate cells, tissues and organs that have been damaged by chronic disease.

((Comments on this story may be sent to

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jun 23, 2015
Previous Article:AOP Orphan Pharmaceuticals makes European regulatory submissions for tetrabenazine.
Next Article:Admune Therapeutics starts patient enrolment in Phase I clinical trial of Heterodimeric IL-15.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters